Annyce Mayer
Anschutz Medical Campus
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Annyce Mayer.
Respiration Physiology | 2001
Annyce Mayer; Lee S. Newman
Chronic Obstructive Pulmonary Disease (COPD) is a leading cause of morbidity and mortality throughout a large part of the western world. Although personal tobacco use has been implicated in a large number of these cases, it is also true that only a fraction of smokers ever develop respiratory problems. Therefore, the question of host susceptibility and other environmental factors should be considered. This paper will briefly review evidence for host susceptibility to COPD, review evidence for additional environmental risk factors for the development of COPD, and give an example of environmental interactions with a known genetic risk factor that further increase the risk of COPD.
American Journal of Industrial Medicine | 2011
D.C. Middleton; Annyce Mayer; Lewin; Margaret M. Mroz; Lisa A. Maier
BACKGROUND The beryllium lymphocyte proliferation test (BeLPT) identifies persons sensitized to beryllium (BeS) and thus at risk for chronic beryllium disease (CBD). BeLPT test results are abnormal (AB), borderline (BL), or normal (NL). This manuscript addresses the predictive value and interpretation of BL BeLPT results. METHODS The various three-result combinations that meet or exceed a nominal referral criteria of 1 AB + 1 BL are assessed with probability modeling and compared. RESULTS At 2% prevalence, the three-result combinations that meet or exceed this referral criteria and associated probabilities of BeS are: (a) 1 AB + 1 BL + 1 NL (72%); (b) 3 BL (91%); (c) 2 AB + 1 NL (95%); (d) 1 AB + 2 BL (99%); (e) 2 AB + 1 BL (100%); and (f) 3 AB (100%). CONCLUSION These results suggest that BL results are meaningful and that three BL results predict BeS across a broad range of population prevalences. An analysis of longitudinal BeLPT results and clinical findings from an actual surveillance program is warranted to confirm the models predictions.
Journal of Occupational and Environmental Medicine | 2015
Annyce Mayer; William J. Brazile; S. Erb; Daniel A. Autenrieth; Kate A. Serrano; M. Van Dyke
Objective: In addition to formaldehyde, workers in salons can be exposed to other chemical irritants, sensitizers, carcinogens, reproductive hazards, infectious agents, ergonomic, and other physical hazards. Worker health and safety training is challenging because of current product labeling practices and the myriad of hazards portending risk for a wide variety of health effects. Methods: Through a Susan B. Harwood Targeted Topic Training grant from the Occupational Safety and Health Administration and assistance from salon development and training partners, we developed, delivered, and validated a health and safety training program using an iterative five-pronged approach. Results: The training was well received and resulted in knowledge gain, improved workplace safety practices, and increased communication about health and safety. Conclusions: These training materials are available for download from the Occupational Safety and Health Administrations Susan B. Harwood Training Grant Program Web site.
American Journal of Industrial Medicine | 2016
Bill Stange; John McInerney; Ashley P. Golden; Wendy Benade; Barbara Neill; Annyce Mayer; Roxana Witter; Liliana Tenney; Kaylan E. Stinson; Donna Cragle; Lee S. Newman
BACKGROUND The National Supplemental Screening Program (NSSP) uses a Total Worker Health(TM) approach to address U.S. Department of Energy (DOE) former worker health. This article provides the design of the integrated occupational health screening and promotion program. METHODS The NSSP implemented a web-based relational health records system to process demographic, exposure, and clinical data. We present medical findings for 12,000 DOE former workers that completed an initial NSSP medical screening between October 1, 2005 and October 4, 2013. We discuss the DOE former worker participant population and the exposure-based and non-occupational medical screening tests used. RESULTS The NSSP identified potential occupationally related health conditions in 40.5% of those screened. Notably, we identified 85.8% of participants with addressable non-occupational health conditions, many of which were previously undiagnosed. CONCLUSION The NSSP demonstrates that the identification of potential occupational health issues in conjunction with addressable non-occupational health conditions provides former workers with information to more effectively manage health.
Respiratory Medicine | 2018
Margaret M. Mroz; John H. Ferguson; Anna V. Faino; Annyce Mayer; Matthew Strand; Lisa A. Maier
BACKGROUND The clinical effects of inhaled corticosteroids (ICS) on chronic beryllium disease (CBD) are unknown. Although frequently used for symptoms or disease not requiring systemic therapy, the clinical course of patients on ICS has not been evaluated. METHODS In a retrospective cohort study, forty-eight subjects with CBD, diagnosed by granulomas on lung biopsy and treated with inhaled corticosteroids, were matched to sixty-eight subjects with CBD who were not treated. Pulmonary function testing, exercise tolerance, blood BeLPT, BAL cell count, and symptoms were evaluated. RESULTS Treated patients showed no significant change over time in pulmonary function, when compared to controls, by forced vital capacity (FVC, p = 0.28) or diffusion capacity (DLCO, p = 0.45) or in exercise tolerance testing. However, symptoms of cough significantly improved in 58% (compared to 17% in controls) and dyspnea improved in 26% after ICS treatment (compared to 0 in controls). Symptoms of cough were improved in patients with a lower baseline FEV1 and FEV1/FVC ratio. Subgroup analysis showed significant lung function response in cases with lower baseline FEV1/FVC and higher residual volume (RV). CONCLUSION Although FVC and DLCO did not improve in the ICS treated group, we saw no difference in decline compared to matched controls. Symptoms of dyspnea and cough improved with ICS especially in those with obstruction and air trapping suggesting that these should be considered an indication of ICS use in CBD patients.
International Journal of Chronic Obstructive Pulmonary Disease | 2006
Annyce Mayer; James K. Stoller; Sverre Vedal; A James Ruttenber; Matt Strand; Robert A. Sandhaus; Lee S. Newman
Murray and Nadel's Textbook of Respiratory Medicine (Sixth Edition) | 2016
Annyce Mayer; Lisa A. Maier
The Journal of Allergy and Clinical Immunology | 2014
Karin A. Pacheco; Annyce Mayer; Samantha Erb; Lata Shirname-More; Lisa A. Maier
american thoracic society international conference | 2012
Annyce Mayer; Peggy M. Mroz; Michael Van Dyke; Lisa A. Maier
american thoracic society international conference | 2012
Elizabeth Barker; Mike Van Dyke; William J. Brazille; Caroline Miller; Samantha Kantrowitz; Margaret M. Mroz; Lisa A. Maier; Annyce Mayer